blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4236939

EP4236939 - CRYSTALLINE AND AMORPHOUS FORMS OF A DELTA-OPIOID MODULATOR [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  04.08.2023
Database last updated on 28.09.2024
FormerThe international publication has been made
Status updated on  07.05.2022
Most recent event   Tooltip09.07.2024Supplementary search reportpublished on 07.08.2024  [2024/32]
Applicant(s)For all designated states
Trevena, Inc.
955 Chesterbrook Blvd, Suite 110
Chesterbrook, PA 19087 / US
[2023/36]
Inventor(s)01 / POLLARD, Victoria
Edinburgh Technopole Milton Bridge EH26 0BE / GB
02 / ALLAN, Laura E. N.
Edinburgh Technopole Milton Bridge EH26 0BE / GB
03 / REECE, Hayley
Edinburgh Technopole Milton Bridge EH26 0BE / GB
04 / KOESTLER, Patrick
Chesterbrook, Pennsylvania 19087 / US
 [2023/36]
Representative(s)Bassil, Nicholas Charles, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2023/36]
Application number, filing date21887402.227.10.2021
[2023/36]
WO2021US56764
Priority number, dateUS202063106202P27.10.2020         Original published format: US 202063106202 P
[2023/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022093904
Date:05.05.2022
Language:EN
[2022/18]
Type: A1 Application with search report 
No.:EP4236939
Date:06.09.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 05.05.2022 takes the place of the publication of the European patent application.
[2023/36]
Search report(s)International search report - published on:US05.05.2022
(Supplementary) European search report - dispatched on:EP08.07.2024
ClassificationIPC:C07D401/14, A61K31/4035, A61K31/445, A61K31/44, A61P25/06, A61P25/16, A61P25/28, A61K31/454, A61K45/06
[2024/32]
CPC:
A61K45/06 (EP,US); C07D401/14 (EP,US); A61K31/454 (EP,US);
A61P25/04 (US); A61P25/06 (EP,US); A61P25/16 (EP);
A61P25/28 (EP); C07B2200/13 (US) (-)
Former IPC [2023/36]A61K31/4035, A61K31/445, A61K31/44, A61P25/06, A61P25/16, A61P25/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/36]
Extension statesBA03.05.2023
ME03.05.2023
Validation statesKH03.05.2023
MA03.05.2023
MD03.05.2023
TN03.05.2023
TitleGerman:KRISTALLINE UND AMORPHE FORMEN EINES DELTA-OPIOID-MODULATORS[2023/36]
English:CRYSTALLINE AND AMORPHOUS FORMS OF A DELTA-OPIOID MODULATOR[2023/36]
French:FORMES CRISTALLINES ET AMORPHES D'UN MODULATEUR DELTA-OPIOÏDE[2023/36]
Entry into regional phase03.05.2023National basic fee paid 
03.05.2023Search fee paid 
03.05.2023Designation fee(s) paid 
03.05.2023Examination fee paid 
Examination procedure03.05.2023Examination requested  [2023/36]
15.12.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
03.05.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US2017210725  (SPEERSCHNEIDER AIMEE CROMBIE [US], et al);
International search[A]WO2005051916  (GLAXO GROUP LTD [GB], et al);
 [A]WO2007039264  (SB PHARMCO INC [US], et al);
 [Y]WO2008139484  (R L FINE CHEM [IN], et al);
 [A]US9168254  (CORSON DONALD T [US], et al);
 [XYA]US2017210725  (SPEERSCHNEIDER AIMEE CROMBIE [US], et al);
 [A]WO2019079540  (EPIZYME INC [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.